Nih

Nih funding pages collect matching grants, scholarships, benefits, fellowships, and other programs from the FindMyMoney.App directory. Use this page to compare current opportunities, then verify deadlines and eligibility on the official source before applying.

RFA-AG-26-011: NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 Independent Clinical Trial Not Allowed)

The NIH National Institute on Aging invites R25 applications for short-term summer research education programs that build a larger AD/ADRD workforce through high school, undergraduate, and science teacher participation, with U.S. submissions due in 2026 and 2027 cycles.

Status: Deadline Passed Type: Grant Amount: NIA intends to commit $1,000,000 in FY 2027 and FY 2028 each; up to 5 new awards per year Deadline: May 27, 2026 Location: United States

RFA-AI-27-012: Coccidioidomycosis Collaborative Research Centers (P01 Clinical Trial Not Allowed)

NIH/NIAID’s 2026 RFA-AI-27-012 supports multi-disciplinary Coccidioidomycosis Collaborative Research Centers focused on Valley fever vaccine progress, with up to three to four P01 awards funded in FY 2027.

Status: Deadline Passed Type: Grant Amount: NIAID intends to commit $4.8M in FY 2027 to fund 3-4 awards Deadline: Jul 9, 2026 Location: United States

RFA-AI-27-016: Tuberculosis Research Advancement Centers (TRACs) (P30, Clinical Trial Not Allowed)

NIH RFA-AI-27-016 opens a center-based tuberculosis research funding route to build TB research infrastructure, training, and clinical/translational capacity through up to five multi-core centers.

Status: Deadline Passed Type: Grant Amount: NIH intends to commit US$4,000,000 in FY27 for up to 5 awards Deadline: Jul 10, 2026 Location: United States

RFA-AR-27-002: HEAL INITIATIVE: INTERACT Data Coordination and Integration Center (U24 Clinical Trial Not Allowed)

The NIH HEAL Initiative seeks a U24 Data Coordination and Integration Center to harmonize and integrate pain-related datasets, including INTERACT consortium outputs, to support evidence-driven pain research and secondary analysis.

Status: Open Type: Grant Deadline: Oct 2, 2026 Location: United States

RFA-AT-25-003: HEAL Initiative Pain Research Enhancement Program (PREP) for R15 Institutions

A NIH HEAL NOFO under R15 to fund basic and mechanistic pain research led by eligible undergraduate-focused, health professional, and graduate institutions, with emphasis on student engagement and interdisciplinary collaboration with NIH partner institutions.

Status: Open Type: Grant Amount: up to $375,000 direct costs requested for entire project period Deadline: Oct 27, 2026 Location: United States

RFA-CA-24-026: National Cancer Institute Youth Enjoy Science Research Education Program (R25)

NIH R25 funding for institutions that design middle-school to undergraduate cancer research education programs, requiring research experiences, curriculum/method development, and outreach.

Status: Open Type: Grant Amount: Maximum $400,000 direct costs per year; project period up to 5 years Deadline: Sep 28, 2026 Location: United States

RFA-CA-27-006: NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required)

A federal clinical-research cooperative agreement for US institutions to serve as NCORP research hubs that run cancer prevention, treatment, symptom-management, and care-delivery trials in community settings.

Status: Open Type: Grant Amount: $74,500,000 total program funding in the FY2027 notice, with up to 7 awards Deadline: Sep 18, 2026 Location: United States

RFA-CA-27-016: The Experimental Therapeutics Clinical Trials Network (ETCTN) Lead Academic Organizations (UM1 Clinical Trial Required)

NIH/NCI’s ETCTN NOFO seeks institutions that can lead early-phase cancer therapeutic trials within the NCI Cancer Therapy Evaluation Program, using the UM1 cooperative agreement model with a strong focus on trial activation, accrual, and mentorship for early career investigators.

Status: Deadline Passed Type: Grant Amount: NIH intends to commit $11.8 million in FY 2027 to fund four to six awards Deadline: Jun 30, 2026 Location: United States and Canada

RFA-CA-27-021: Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

NCI’s RFA-CA-27-021 supports advanced and widely adopted cancer informatics resources through U24 sustained-support awards, with $1.8 million committed in FY 2027 across two awards.

Status: Deadline Passed Type: Grant Amount: $600,000 direct costs per year (up to), $1.8 million total committed for two awards Deadline: Jul 1, 2026 Location: United States

RFA-DA-26-034: Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on the Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic Opioids

NIH Trans-NIH RFA supports basic and applied research on acute exposure effects and delayed effects of ultra-potent synthetic opioids, with recurring R01 due dates in 2026 and 2027.

Status: Open Type: Grant Amount: NIH intends up to 4 awards and $2M total in FY 2026 Deadline: Nov 18, 2026 Location: United States and U.S. territories and possessions